{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:04:23Z","timestamp":1791414263798,"version":"4.3.3"},"reference-count":437,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["1107356"],"award-info":[{"award-number":["1107356"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1143296"],"award-info":[{"award-number":["GNT1143296"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.addr.2022.114293","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T23:14:48Z","timestamp":1650928488000},"page":"114293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Advances and future perspectives in epithelial drug delivery"],"prefix":"10.1016","volume":"186","author":[{"given":"Yousuf","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Chi Lip","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Kumeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Namjoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Matteucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiting","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.E.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2022.114293_b0005","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1015802427428","article-title":"The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit","volume":"9","author":"Rojanasakul","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0010","series-title":"Physical and Biophysical Foundations of Pharmacy Practice: Issues in Drug Delivery","author":"Flynn","year":"2015"},{"key":"10.1016\/j.addr.2022.114293_b0015","doi-asserted-by":"crossref","first-page":"113929","DOI":"10.1016\/j.addr.2021.113929","article-title":"Topical drug delivery: history, percutaneous absorption, and product development","volume":"177","author":"Roberts","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/pharmaceutics10040263","article-title":"A comprehensive map of FDA-approved pharmaceutical products","volume":"10","author":"Zhong","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00970002042006005","article-title":"A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals","volume":"42","author":"Martinez","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b0030","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). M9 Biopharmaceutics Classification System - Based Biowaivers. Guidance for Industry. May 2021 https:\/\/www.fda.gov\/media\/148472\/download ."},{"key":"10.1016\/j.addr.2022.114293_b0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114293_b0040","unstructured":"World Health Organization. Annex 8. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms. WHO Technical Report Series, No. 937, 2006."},{"key":"10.1016\/j.addr.2022.114293_b0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2021.08.005","article-title":"Nanocarriers for oral delivery of biologics: small carriers for big payloads","volume":"42","author":"Cao","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0050","first-page":"31","article-title":"An Introduction for Pharmacists, O.H. Practitioners, Status of Biologic Drugs in Modern Therapeutics-Targeted Therapies vs. Small Molecule","author":"Midlam","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2022.114293_b0055","doi-asserted-by":"crossref","unstructured":"M.S. Hedrington, S.N.J.E.o.o.p. Davis, Oral semaglutide for the treatment of type 2 diabetes, 20 (2019) 133-141.","DOI":"10.1080\/14656566.2018.1552258"},{"key":"10.1016\/j.addr.2022.114293_b0060","unstructured":"E.N. Marieb, K. Hoehn, Human anatomy & physiology, Pearson education2007."},{"key":"10.1016\/j.addr.2022.114293_b0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1749-6632.2009.04025.x","article-title":"Dynamic regulation of epithelial cell fate and barrier function by intercellular junctions","volume":"1165","author":"Koch","year":"2009","journal-title":"Ann. New York Acad. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/ijms21030972","article-title":"The integral role of tight junction proteins in the repair of injured intestinal epithelium","volume":"21","author":"Slifer","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0075","doi-asserted-by":"crossref","unstructured":"B.R. Stevenson, J.D. Siliciano, M.S. Mooseker, D.A. Goodenough, Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia, 103 (1986) 755-766.","DOI":"10.1083\/jcb.103.3.755"},{"key":"10.1016\/j.addr.2022.114293_b0080","first-page":"681","article-title":"Surface area of the digestive tract\u2013revisited, Scandinavian","volume":"49","author":"Helander","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.addr.2022.114293_b0085","series-title":"Gastrointestinal anatomy and physiology: the essentials","author":"Reinus","year":"2014"},{"key":"10.1016\/j.addr.2022.114293_b0090","unstructured":"C. Huttenhower, D. Gevers, R. Knight, S. Abubucker, J.H. Badger, A.T. Chinwalla, H.H. Creasy, A.M. Earl, M.G. FitzGerald, R.S. Fulton, M.G. Giglio, K. Hallsworth-Pepin, E.A. Lobos, R. Madupu, V. Magrini, J.C. Martin, M. Mitreva, D.M. Muzny, E.J. Sodergren, J. Versalovic, A.M. Wollam, K.C. Worley, J.R. Wortman, S.K. Young, Q. Zeng, K.M. Aagaard, O.O. Abolude, E. Allen-Vercoe, E.J. Alm, L. Alvarado, G.L. Andersen, S. Anderson, E. Appelbaum, H.M. Arachchi, G. Armitage, C.A. Arze, T. Ayvaz, C.C. Baker, L. Begg, T. Belachew, V. Bhonagiri, M. Bihan, M.J. Blaser, T. Bloom, V. Bonazzi, J. Paul Brooks, G.A. Buck, C.J. Buhay, D.A. Busam, J.L. Campbell, S.R. Canon, B.L. Cantarel, P.S.G. Chain, I.M.A. Chen, L. Chen, S. Chhibba, K. Chu, D.M. Ciulla, J.C. Clemente, S.W. Clifton, S. Conlan, J. Crabtree, M.A. Cutting, N.J. Davidovics, C.C. Davis, T.Z. DeSantis, C. Deal, K.D. Delehaunty, F.E. Dewhirst, E. Deych, Y. Ding, D.J. Dooling, S.P. Dugan, W. Michael Dunne, A. Scott Durkin, R.C. Edgar, R.L. Erlich, C.N. Farmer, R.M. Farrell, K. Faust, M. Feldgarden, V.M. Felix, S. Fisher, A.A. Fodor, L.J. Forney, L. Foster, V. Di Francesco, J. Friedman, D.C. Friedrich, C.C. Fronick, L.L. Fulton, H. Gao, N. Garcia, G. Giannoukos, C. Giblin, M.Y. Giovanni, J.M. Goldberg, J. Goll, A. Gonzalez, A. Griggs, S. Gujja, S. Kinder Haake, B.J. Haas, H.A. Hamilton, E.L. Harris, T.A. Hepburn, B. Herter, D.E. Hoffmann, M.E. Holder, C. Howarth, K.H. Huang, S.M. Huse, J. Izard, J.K. Jansson, H. Jiang, C. Jordan, V. Joshi, J.A. Katancik, W.A. Keitel, S.T. Kelley, C. Kells, N.B. King, D. Knights, H.H. Kong, O. Koren, S. Koren, K.C. Kota, C.L. Kovar, N.C. Kyrpides, P.S. La Rosa, S.L. Lee, K.P. Lemon, N. Lennon, C.M. Lewis, L. Lewis, R.E. Ley, K. Li, K. Liolios, B. Liu, Y. Liu, C.-C. Lo, C.A. Lozupone, R. Dwayne Lunsford, T. Madden, A.A. Mahurkar, P.J. Mannon, E.R. Mardis, V.M. Markowitz, K. Mavromatis, J.M. McCorrison, D. McDonald, J. McEwen, A.L. McGuire, P. McInnes, T. Mehta, K.A. Mihindukulasuriya, J.R. Miller, P.J. Minx, I. Newsham, C. Nusbaum, M. O\u2019Laughlin, J. Orvis, I. Pagani, K. Palaniappan, S.M. Patel, M. Pearson, J. Peterson, M. Podar, C. Pohl, K.S. Pollard, M. Pop, M.E. Priest, L.M. Proctor, X. Qin, J. Raes, J. Ravel, J.G. Reid, M. Rho, R. Rhodes, K.P. Riehle, M.C. Rivera, B. Rodriguez-Mueller, Y.-H. Rogers, M.C. Ross, C. Russ, R.K. Sanka, P. Sankar, J. Fah Sathirapongsasuti, J.A. Schloss, P.D. Schloss, T.M. Schmidt, M. Scholz, L. Schriml, A.M. Schubert, N. Segata, J.A. Segre, W.D. Shannon, R.R. Sharp, T.J. Sharpton, N. Shenoy, N.U. Sheth, G.A. Simone, I. Singh, C.S. Smillie, J.D. Sobel, D.D. Sommer, P. Spicer, G.G. Sutton, S.M. Sykes, D.G. Tabbaa, M. Thiagarajan, C.M. Tomlinson, M. Torralba, T.J. Treangen, R.M. Truty, T.A. Vishnivetskaya, J. Walker, L. Wang, Z. Wang, D.V. Ward, W. Warren, M.A. Watson, C. Wellington, K.A. Wetterstrand, J.R. White, K. Wilczek-Boney, Y. Wu, K.M. Wylie, T. Wylie, C. Yandava, L. Ye, Y. Ye, S. Yooseph, B.P. Youmans, L. Zhang, Y. Zhou, Y. Zhu, L. Zoloth, J.D. Zucker, B.W. Birren, R.A. Gibbs, S.K. Highlander, B.A. Meth\u00e9, K.E. Nelson, J.F. Petrosino, G.M. Weinstock, R.K. Wilson, O. White, C. The Human Microbiome Project, Structure, function and diversity of the healthy human microbiome, Nature 486 (2012) 207-214."},{"key":"10.1016\/j.addr.2022.114293_b0095","first-page":"274","volume":"154","author":"Clevers","year":"2013","journal-title":"The intestinal crypt, a prototype stem cell compartment"},{"key":"10.1016\/j.addr.2022.114293_b0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.actbio.2021.03.042","article-title":"Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery","volume":"126","author":"Raza","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2022.114293_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17425247.2017.1395853","article-title":"Strategies and industrial perspectives to improve oral absorption of biological macromolecules","volume":"15","author":"Liu","year":"2018","journal-title":"Expert opinion on drug delivery"},{"key":"10.1016\/j.addr.2022.114293_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00219","article-title":"Lipid-based nano-delivery systems for skin delivery of drugs and bioactives","volume":"6","author":"Hua","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b0120","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s11095-008-9580-9","article-title":"Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems","volume":"25","author":"Ibekwe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","article-title":"Gut instincts: explorations in intestinal physiology and drug delivery","volume":"364","author":"McConnell","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b0130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.cgh.2014.06.018","article-title":"Polymeric nanoparticle technologies for oral drug delivery","volume":"12","author":"Pridgen","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2022.114293_b0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jccs.201190121","article-title":"Chitosan\/fucoidan pH sensitive nanoparticles for oral delivery system","volume":"58","author":"Huang","year":"2011","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.addr.2022.114293_b0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0145","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.ijbiomac.2017.10.128","article-title":"Facile fabrication and characterization of a novel oral pH-sensitive drug delivery system based on CMC hydrogel and HNT-AT nanohybrid","volume":"107","author":"Hossieni-Aghdam","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2022.114293_b0150","article-title":"Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody","author":"Kumeria","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2022.114293_b0155","first-page":"61","article-title":"Enzymatic barriers for GI peptide and protein delivery","volume":"11","author":"Woodley","year":"1994","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2022.114293_b0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2022.114293_b0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: Current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.addr.2022.114293_b0170","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1039\/C7NR05762H","article-title":"Evaluation of mesoporous silica nanoparticles for oral drug delivery\u2013current status and perspective of MSNs drug carriers","volume":"9","author":"Florek","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2022.114293_b0175","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17425247.2016.1211639","article-title":"In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration","volume":"14","author":"Joubert","year":"2017","journal-title":"Expert opinion on drug delivery"},{"key":"10.1016\/j.addr.2022.114293_b0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nnm.13.26","article-title":"Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus","volume":"9","author":"Laffleur","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2022.114293_b0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/aja.1001410403","article-title":"Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine I. Columnar cell","volume":"141","author":"Cheng","year":"1974","journal-title":"Am. J. Anatomy"},{"key":"10.1016\/j.addr.2022.114293_b0200","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.25247","article-title":"Claudin interactions in and out of the tight junction","volume":"1","author":"Van Itallie","year":"2013","journal-title":"Tissue barriers"},{"key":"10.1016\/j.addr.2022.114293_b0205","first-page":"1245","article-title":"Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery, Nanomedicine: Nanotechnology","volume":"13","author":"Mandracchia","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2022.114293_b0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0169-409X(95)00131-P","article-title":"The potential use of receptor-mediated endocytosis for oral drug delivery","volume":"20","author":"Russell-Jones","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4161\/tisb.23496","article-title":"A complex affair: Attraction and repulsion make occludin and ZO-1 function!","volume":"1","author":"Bewley","year":"2013","journal-title":"Tissue barriers"},{"key":"10.1016\/j.addr.2022.114293_b0220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibtech.2009.07.009","article-title":"Therapeutic application of peptides and proteins: parenteral forever?","volume":"27","author":"Antosova","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0230","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2022.114293_b0235","doi-asserted-by":"crossref","unstructured":"M.d.C.F. PASSOS, J.P. MORAES-FILHO, Intestinal microbiota in digestive diseases, Arquivos de gastroenterologia, 54 (2017) 255-262.","DOI":"10.1590\/s0004-2803.201700000-31"},{"key":"10.1016\/j.addr.2022.114293_b0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5740\/jaoacint.SGE_Macfarlane","article-title":"Bacteria, colonic fermentation, and gastrointestinal health","volume":"95","author":"Macfarlane","year":"2012","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.addr.2022.114293_b0245","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MCG.0000000000000153","article-title":"Intestinal microbiota: its role in digestive diseases","volume":"48","author":"Fernandez","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2022.114293_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/003655201753265082","article-title":"The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics","volume":"36","author":"Linskens","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.addr.2022.114293_b0255","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2014.01.058","article-title":"Diet and the intestinal microbiome: associations, functions, and implications for health and disease","volume":"146","author":"Albenberg","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2022.114293_b0260","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2022.114293_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.09.003","article-title":"Challenges and innovations of drug delivery in older age","volume":"135","author":"Khan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/neuonc\/now155","article-title":"Long-term survival in AIDS-related primary central nervous system lymphoma","volume":"19","author":"Gupta","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.addr.2022.114293_b0275","first-page":"20","article-title":"The history of therapeutic aerosols: A chronological review, Journal of Aerosol Medicine and Pulmonary","volume":"30","author":"Stein","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b0280","series-title":"Morphometry of the Human Lung","author":"Weibel","year":"1963"},{"key":"10.1016\/j.addr.2022.114293_b0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaerosci.2019.04.015","article-title":"CFD modelling of air and particle flows in different airway models","volume":"134","author":"Kim","year":"2019","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.addr.2022.114293_b0290","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1114\/1.1560632","article-title":"Computational fluid dynamics simulation of airflow and aerosol deposition in human lungs","volume":"31","author":"Nowak","year":"2003","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2022.114293_b0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/027868200303939","article-title":"Computational fluid dynamic predictions and experimental results for particle deposition in an airway model","volume":"32","author":"Oldham","year":"2000","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105233","article-title":"Development of human respiratory airway models: A review","volume":"145","author":"Ahookhosh","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1513\/pats.2306014","article-title":"Regulation of airway surface liquid volume and mucus transport by active ion transport","volume":"1","author":"Tarran","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.addr.2022.114293_b0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028241","article-title":"Cilia and mucociliary clearance","volume":"9","author":"Bustamante-Marin","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.addr.2022.114293_b0315","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1469-7580.2002.00098.x","article-title":"Regulation of the depth and composition of airway surface liquid","volume":"201","author":"Widdicombe","year":"2002","journal-title":"J. Anat."},{"key":"10.1016\/j.addr.2022.114293_b0320","series-title":"Inhalation Drug Delivery: Techniques and Products","article-title":"Inhalation drug delivery","author":"Traini","year":"2013"},{"key":"10.1016\/j.addr.2022.114293_b0325","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/jappl.1990.69.1.362","article-title":"Mathematical modeling of heat and water transport in human respiratory tract","volume":"69","author":"Daviskas","year":"1990","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2022.114293_b0330","first-page":"S32","article-title":"Comparative subgross anatomy of the lungs","volume":"128","author":"Tyler","year":"1983","journal-title":"Pleuras, interlobular septa, and distal airways, American Review of Respiratory Disease"},{"key":"10.1016\/j.addr.2022.114293_b0335","first-page":"332","article-title":"Cell number and cell characteristics of the normal human lung","volume":"126","author":"Crapo","year":"1982","journal-title":"American Review of Respiratory Disease"},{"key":"10.1016\/j.addr.2022.114293_b0340","first-page":"366","article-title":"Cells of the lung: Biology and clinical implications","volume":"127","author":"Gail","year":"1983","journal-title":"American Review of Respiratory Disease"},{"key":"10.1016\/j.addr.2022.114293_b0345","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","article-title":"Emerging insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: Towards prediction of nose-to-brain transport in humans","volume":"17","author":"Ruigrok","year":"2015","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.addr.2022.114293_b0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery \u2014 Possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b0355","series-title":"Comparative Biology of the Normal Lung","article-title":"Deposition of particles","author":"Brown","year":"2015"},{"key":"10.1016\/j.addr.2022.114293_b0360","series-title":"Pharmaceutical Inhalation Aerosol Technology","article-title":"Bioequivalence of orally inhaled drug products: Challenges and opportunities","author":"Hastedt","year":"2019"},{"key":"10.1016\/j.addr.2022.114293_b0365","series-title":"Pulmonary Drug Delivery: Advances and Challenges","article-title":"Lung anatomy and physiology and their implications for pulmonary drug delivery","author":"Verma","year":"2015"},{"key":"10.1016\/j.addr.2022.114293_b0370","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11095-010-0332-2","article-title":"Formation of protein nano-matrix particles with controlled surface architecture for respiratoy drug delivery","volume":"28","author":"Kwok","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0375","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/02786826.2011.566592","article-title":"Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols","volume":"45","author":"Longest","year":"2011","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b0380","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1007\/s10439-012-0616-2","article-title":"Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways","volume":"40","author":"Longest","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2022.114293_b0385","first-page":"248","article-title":"Targeting aerosol deposition to and within the lung airways using excipient enhanced growth Journal of Aerosol Medicine and Pulmonary","volume":"26","author":"Tian","year":"2013","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b0390","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1111\/bph.15197","article-title":"Cough as an adverse effect for inhalation pharmaceutical products","volume":"177","author":"Chang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b0395","series-title":"Optimisation of Dry Powder Inhalation: The Application of Air Classifier and Laser Diffraction Technology for the Generation and Characterisation of Aerosols from Adhesive Mixtures","author":"de Boer","year":"2005"},{"key":"10.1016\/j.addr.2022.114293_b0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2018.07.030","article-title":"Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties","volume":"123","author":"Ambrus","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0405","series-title":"Inhalation Drug Delivery: Techniques and Products","article-title":"Inhalation and nasal products","author":"Traini","year":"2013"},{"key":"10.1016\/j.addr.2022.114293_b0410","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0091-6749(93)90125-Y","article-title":"Estimation of nasal epithelial lining fluid using urea as a marker","volume":"92","author":"Kaulbach","year":"1993","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2022.114293_b0415","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b0420","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/acs.cgd.8b01873","article-title":"Cocrystal engineering of itraconazole with suberic acid via rotary evaporation and spray drying","volume":"19","author":"Weng","year":"2019","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.addr.2022.114293_b0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejpb.2017.02.013","article-title":"Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations","volume":"115","author":"Karashima","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2022.114293_b0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2016.01.002","article-title":"Amorphous powders for inhalation drug delivery","volume":"100","author":"Chen","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.08.010","article-title":"Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former","volume":"420","author":"Yamasaki","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b0440","series-title":"Aulton's Pharmaceutics: The Design and Manufacture of Medicines","article-title":"Nasal drug delivery","author":"Martin","year":"2018"},{"key":"10.1016\/j.addr.2022.114293_b0445","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9\u201339) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2022.114293_b0450","series-title":"Challenges in Delivery of Therapeutic Genomics and Proteomics","article-title":"Protein and peptide delivery through respiratory pathway","author":"Tandel","year":"2011"},{"key":"10.1016\/j.addr.2022.114293_b0455","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/thx.38.6.463","article-title":"Impaired tracheobronchial clearance in patients with mild stable asthma","volume":"38","author":"Bateman","year":"1983","journal-title":"Thorax"},{"key":"10.1016\/j.addr.2022.114293_b0460","series-title":"Pharmaceutical Inhalation Aerosol Technology","article-title":"Physiology of the airways","author":"Hickey","year":"2019"},{"key":"10.1016\/j.addr.2022.114293_b0465","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40248-015-0012-5","article-title":"Dry powder inhalers and the right things to remember: a concept review","volume":"10","author":"Dal Negro","year":"2015","journal-title":"Multidisc. Respir. Med."},{"key":"10.1016\/j.addr.2022.114293_b0470","first-page":"89","article-title":"The role of airway mucus in pulmonary toxicology","volume":"102","author":"Samet","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.addr.2022.114293_b0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.addr.2022.114293_b0480","series-title":"Inhalation Aerosols: Physical and Biological Basis for Therapy","article-title":"Fundamentals in nasal drug delivery","author":"Warnken","year":"2019"},{"key":"10.1016\/j.addr.2022.114293_b0485","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00137696-200604040-00004","article-title":"Solid lipid nanoparticles for topical drug delivery","volume":"4","author":"Zhang","year":"2006","journal-title":"Am. J. Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b0490","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1289\/ehp.8861","article-title":"Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers","volume":"114","author":"Thum","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.addr.2022.114293_b0495","series-title":"Pharmaceutical Inhalation Aerosol Technology","article-title":"Drug Targeting to the Lung: Chemical and Biochemical Considerations","author":"Crooks","year":"2019"},{"key":"10.1016\/j.addr.2022.114293_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1018911206646","article-title":"Drug metabolism in the nasal mucosa","volume":"9","author":"Sarkar","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0505","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1248\/cpb.39.2155","article-title":"Study of nasal enzyme activity towards insulin. In vitro","volume":"39","author":"Gizurarson","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.addr.2022.114293_b0510","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1023\/A:1016292232513","article-title":"The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits","volume":"12","author":"Colthorpe","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0515","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: Delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.addr.2022.114293_b0520","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2012.04.012","article-title":"Absorption-promoting effects of chitosan in airway and intestinal cell lines: A comparative study","volume":"430","author":"Vllasaliu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b0525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0530","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2004.10.010","article-title":"Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions","volume":"102","author":"Yamamoto","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1517\/17425255.4.4.333","article-title":"In vitro cell culture models for the assessment of pulmonary drug disposition","volume":"4","author":"Sporty","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.addr.2022.114293_b0540","series-title":"Controlled Pulmonary Drug Delivery","article-title":"Pulmonary drug metabolism, clearance, and absorption","author":"Olsson","year":"2011"},{"key":"10.1016\/j.addr.2022.114293_b0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0550","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.07.025","article-title":"In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs","volume":"161\u2013162","author":"Sakagami","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0555","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.addr.2020.09.008","article-title":"Building three-dimensional lung models for studying pharmacokinetics of inhaled drugs","volume":"170","author":"Barros","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0560","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2020.06.029","article-title":"Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals","volume":"167","author":"S\u00e9cher","year":"2020","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.addr.2022.114293_b0565","unstructured":"ReportLinker, Pulmonary Drug Delivery Systems Market by Product, Application, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2030, 2022."},{"key":"10.1016\/j.addr.2022.114293_b0570","unstructured":"ReportLinker, Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type ; Delivery Technologies ; End User, and Geography, 2022."},{"key":"10.1016\/j.addr.2022.114293_b0575","unstructured":"U.S.F.a.D. Administration, Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, 2022."},{"key":"10.1016\/j.addr.2022.114293_b0580","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1208\/s12248-015-9733-9","article-title":"International guidelines for bioequivalence of locally acting orally inhaled drug products: Similarities and differences","volume":"17","author":"Lu","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114293_b0585","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1208\/s12248-015-9787-8","article-title":"Regulatory considerations for approval of generic inhalation drug products in the US, EU, Brazil, China, and India","volume":"17","author":"Lee","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114293_b0590","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1208\/s12248-015-9736-6","article-title":"Pharmacokinetics of orally inhaled drug products","volume":"17","author":"Hochhaus","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114293_b0595","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40262-016-0438-8","article-title":"Bioequivalence evaluations of generic dry powder inhaler drug products: Similarities and differences between Japan, USA, and the European Union","volume":"56","author":"Kuribayashi","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2022.114293_b0600","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/jamp.2011.0968","article-title":"Equivalence considerations for orally inhaled products for local action-ISAM\/IPAC-RS European Workshop report","volume":"25","author":"Evans","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.addr.2022.114293_b0605","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40290-014-0065-3","article-title":"Approval of generic fluticasone propionate\/salmeterol xinafoate dry powder inhalers in the US: A difficult exercise in regulatory science","volume":"28","author":"Fuglsang","year":"2014","journal-title":"Pharm. Med."},{"key":"10.1016\/j.addr.2022.114293_b0610","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s13346-020-00817-1","article-title":"First approval of generic dry powder inhaler drug products in Japan","volume":"10","author":"Kuribayashi","year":"2020","journal-title":"Drug Delivery Translational Res."},{"key":"10.1016\/j.addr.2022.114293_b0615","unstructured":"T.C.D.S.C. Organisation, Guidelines for bioavailability and equivalence studies, 2005."},{"key":"10.1016\/j.addr.2022.114293_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113895","article-title":"Bioequivalence assessment of pharmaceutical aerosol products through IVIVC","volume":"176","author":"Sandell","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0625","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/ci800429e","article-title":"Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet?","volume":"49","author":"Ritchie","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.addr.2022.114293_b0630","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s11095-016-1983-4","article-title":"Development of a novel quantitative structure-activity relationship model to accurately predict pulmonary absorption and replace routine use of the isolated perfused respiring rat lung model","volume":"33","author":"Edwards","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b0635","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/pharmaceutics13071056","article-title":"Pulmonary drug delivery of antimicrobials and anticancer drugs using solid dispersions","volume":"13","author":"Al-Obaidi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b0640","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: A promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b0645","unstructured":"H.-K. Chan, R.Y.K. Chang, Inhaled delivery of anti-pseudomonal phages to tackle respiratory infections caused by superbugs, Journal of Aerosol Medicine and Pulmonary Drug Delivery, (In Press)."},{"key":"10.1016\/j.addr.2022.114293_b0650","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA therapy: From promise to reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0655","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0106-2021","article-title":"Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration","volume":"31","author":"Kadota","year":"2022","journal-title":"Eur. Respiratory Rev."},{"key":"10.1016\/j.addr.2022.114293_b0660","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41587-020-0692-z","article-title":"Mist begins to clear for lung delivery of RNA","volume":"38","author":"Shaffer","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b0665","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/antibiotics9110827","article-title":"Phage therapy: Towards a successful clinical trial","volume":"9","author":"G\u00f3rski","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.addr.2022.114293_b0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01890888","article-title":"Advances in contraception","volume":"5","author":"Zatuchni","year":"1989","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.addr.2022.114293_b0675","unstructured":"N.E. Himes, Medical history of contraception, 2021."},{"key":"10.1016\/j.addr.2022.114293_b0680","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)08541-6","article-title":"On the absorption of drugs and poisons through the vagina","volume":"10","author":"Macht","year":"1918","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2022.114293_b0685","first-page":"628","article-title":"Lactic Acid, Citric Acid, and Potassium Bitartrate (Phexxi) Vaginal Gel for Contraception","volume":"103","author":"Steinberg","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.addr.2022.114293_b0690","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12249-008-9073-5","article-title":"A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV\/AIDS and prevention of sexually transmitted infections","volume":"9","author":"Ndesendo","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2022.114293_b0695","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SPV.0000000000000387","article-title":"Histologic anatomy of the anterior vagina and urethra","volume":"23","author":"Mazloomdoost","year":"2017","journal-title":"Female Pelvic Med. Reconstruct. Surg."},{"key":"10.1016\/j.addr.2022.114293_b0700","series-title":"Embryology, Anatomy, and Histology of the Vagina","first-page":"685","author":"Buy","year":"2013"},{"key":"10.1016\/j.addr.2022.114293_b0705","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0003-9969(01)00082-6","article-title":"A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium","volume":"46","author":"Thompson","year":"2001","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.addr.2022.114293_b0710","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","article-title":"Structure and Function of Intercellular Junctions in Human Cervical and Vaginal Mucosal Epithelia1","volume":"85","author":"Blaskewicz","year":"2011","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.addr.2022.114293_b0715","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000070184","article-title":"Surface area of the human vagina as measured from vinyl polysiloxane casts","volume":"55","author":"Pendergrass","year":"2003","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.addr.2022.114293_b0720","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000291946","article-title":"The shape and dimensions of the human vagina as seen in three-dimensional vinyl polysiloxane casts","volume":"42","author":"Pendergrass","year":"1996","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.addr.2022.114293_b0725","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/del022","article-title":"Baseline dimensions of the human vagina","volume":"21","author":"Barnhart","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.addr.2022.114293_b0730","article-title":"Comprehensive gynecology E-book","author":"Lobo","year":"2016","journal-title":"Elsevier Health Sci."},{"key":"10.1016\/j.addr.2022.114293_b0735","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2003.11.006","article-title":"Diaphragms in clinical trials: is clinician fitting necessary?","volume":"69","author":"Mauck","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2022.114293_b0740","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000293685","article-title":"Morphometric characteristics of the vaginal epithelium during the menstrual cycle","volume":"26","author":"Sjoberg","year":"1988","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.addr.2022.114293_b0745","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b0750","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1067\/mob.2000.108857","article-title":"Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle","volume":"183","author":"Patton","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0755","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13697130500042490","article-title":"Vaginal rugae: measurement and significance","volume":"8","author":"Whiteside","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.addr.2022.114293_b0760","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal Atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.addr.2022.114293_b0765","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/IJGM.S43192","article-title":"Barriers to effective treatment of vaginal atrophy with local estrogen therapy","volume":"6","author":"Reiter","year":"2013","journal-title":"Int. J. General Med."},{"key":"10.1016\/j.addr.2022.114293_b0770","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/aji.12230","article-title":"The structure of the human vaginal stratum corneum and its role in immune defense","volume":"71","author":"Anderson","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.addr.2022.114293_b0775","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.04.017","article-title":"Vaginal drug distribution modeling","volume":"92","author":"Katz","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0780","first-page":"983","article-title":"Vaginal mucosa\u2013a promising site for drug therapy","author":"Kale","year":"2013","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.addr.2022.114293_b0785","doi-asserted-by":"crossref","unstructured":"J.d. Neves, R. Palmeira\u2010de\u2010Oliveira, A. Palmeira\u2010de\u2010Oliveira, F. Rodrigues, B. Sarmento, Vaginal mucosa and drug delivery, Mucoadhesive materials and drug delivery systems, (2014) 99-132.","DOI":"10.1002\/9781118794203.ch05"},{"key":"10.1016\/j.addr.2022.114293_b0790","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543776.2012.714369","article-title":"Innovations in bioadhesive vaginal drug delivery system","volume":"22","author":"Bassi","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.addr.2022.114293_b0795","doi-asserted-by":"crossref","unstructured":"W.M. McCormack, M.H. Augenbraun, Vulvovaginitis and cervicitis, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Elsevier2015, pp. 1358-1371. e1352.","DOI":"10.1016\/B978-1-4557-4801-3.00110-7"},{"key":"10.1016\/j.addr.2022.114293_b0800","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2022.114293_b0805","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1021\/mp300408m","article-title":"Interactions of microbicide nanoparticles with a simulated vaginal fluid","volume":"9","author":"das Neves","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b0810","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12866-020-02027-8","article-title":"Adaptive response to iterative passages of five Lactobacillus species in simulated vaginal fluid","volume":"20","author":"Brandt","year":"2020","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.addr.2022.114293_b0815","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.3390\/ijms21218266","article-title":"The Cervicovaginal Mucus Barrier","volume":"21","author":"Lacroix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2022.114293_b0820","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/jsm.12583","article-title":"Activation of \u03b2-adrenergic receptors during sexual arousal facilitates vaginal lubrication by regulating vaginal epithelial Cl\u2212 secretion","volume":"11","author":"Sun","year":"2014","journal-title":"J. Sexual Med."},{"key":"10.1016\/j.addr.2022.114293_b0825","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1111\/j.1743-6109.2010.01810.x","article-title":"Physiology of women's sexual function: basic knowledge and new findings","volume":"7","author":"Salonia","year":"2010","journal-title":"J. Sexual Med."},{"key":"10.1016\/j.addr.2022.114293_b0830","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","article-title":"The role of lactic acid production by probiotic Lactobacillus species in vaginal health","volume":"168","author":"Tachedjian","year":"2017","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.addr.2022.114293_b0835","doi-asserted-by":"crossref","first-page":"e00460","DOI":"10.1128\/mBio.00460-13","volume":"4","author":"Witkin","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.addr.2022.114293_b0840","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GME.0b013e3182a4690b","article-title":"Association between the vaginal microbiota, menopause status and signs of vulvovaginal atrophy","volume":"21","author":"Brotman","year":"2014","journal-title":"Menopause (New York, NY)"},{"key":"10.1016\/j.addr.2022.114293_b0845","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/GME.0000000000001081","article-title":"Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women","volume":"25","author":"Tucker","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.addr.2022.114293_b0850","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajog.2003.12.015","article-title":"Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis","volume":"190","author":"Roy","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0855","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/GME.0000000000000397","article-title":"Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women","volume":"22","author":"Mirmonsef","year":"2015","journal-title":"Menopause (New York N.Y.)"},{"key":"10.1016\/j.addr.2022.114293_b0860","doi-asserted-by":"crossref","unstructured":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society, Menopause, 14 (2007) 357-369.","DOI":"10.1097\/gme.0b013e31805170eb"},{"key":"10.1016\/j.addr.2022.114293_b0865","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/503780","article-title":"High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2022.114293_b0870","unstructured":"N. Patel, J. Banker, B. Leuva, U. Patel, K. Chauhan, A study of postpartum bacterial vaginal flora, (2017)."},{"key":"10.1016\/j.addr.2022.114293_b0875","doi-asserted-by":"crossref","DOI":"10.1097\/NMC.0b013e3181cae9da","article-title":"An updated review of of evidence to discourage douching, MCN","volume":"35","author":"Cottrell","year":"2010","journal-title":"Am. J. Maternal\/Child Nursing"},{"key":"10.1016\/j.addr.2022.114293_b0880","first-page":"454","article-title":"Gardnerella vaginalis clade distribution is associated with behavioral practices and Nugent score in women who have sex with women","volume":"221","author":"Plummer","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2022.114293_b0885","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/jac\/dkt156","article-title":"Vaginal concentrations of lactic acid potently inactivate HIV","volume":"68","author":"Aldunate","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2022.114293_b0890","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","article-title":"Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis","volume":"382","author":"Cohen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2022.114293_b0895","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fmicb.2016.01936","article-title":"Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique?","volume":"7","author":"Miller","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2022.114293_b0900","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/aid.2011.0071","article-title":"A comparison of lower genital tract glycogen and lactic acid levels in women and macaques: implications for HIV and SIV susceptibility","volume":"28","author":"Mirmonsef","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.addr.2022.114293_b0905","series-title":"Encyclopedia of reproduction","author":"Skinner","year":"2018"},{"key":"10.1016\/j.addr.2022.114293_b0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-15-1070","article-title":"Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis","volume":"15","author":"Ojala","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.addr.2022.114293_b0915","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00203-016-1225-5","article-title":"Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lactobacillus rhamnosus CRL 1332: kinetics of formation and matrix characterization","volume":"198","author":"Leccese Terraf","year":"2016","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.addr.2022.114293_b0920","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/5.4.365","article-title":"New Hypotheses. Transvaginal progesterone: evidence for a new functional'portal system'flowing from the vagina to the uterus","volume":"5","author":"Cicinelli","year":"1999","journal-title":"Hum. Reproduction Update"},{"key":"10.1016\/j.addr.2022.114293_b0925","first-page":"693","article-title":"Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women","volume":"72","author":"Vermesh","year":"1988","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0930","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/152460901317193567","article-title":"Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study","volume":"10","author":"Shantha","year":"2001","journal-title":"J. Women's Health Gender-based Med."},{"key":"10.1016\/j.addr.2022.114293_b0935","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0029-7844(97)00270-6","article-title":"Transvaginal administration of progesterone","volume":"90","author":"Fanchin","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0940","first-page":"403","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"Cicinelli","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0945","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","article-title":"The scope and potential of vaginal drug delivery","volume":"3","author":"Vermani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.addr.2022.114293_b0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2022.114293_b0955","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b0960","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/10717544.2021.1912211","article-title":"Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal emulgel for management of bacterial vaginosis and its recurrence","volume":"28","author":"Badawi","year":"2021","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b0965","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/1381612820666141029150427","article-title":"Nano-sized platforms for vaginal drug delivery","volume":"21","author":"El-Hammadi","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2022.114293_b0970","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aai9383","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women","volume":"356","author":"Klatt","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114293_b0975","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/pharmaceutics11050217","article-title":"Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities","volume":"11","author":"Leyva-G\u00f3mez","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b0980","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1211\/0022357011778034","article-title":"Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans","volume":"53","author":"Acart\u00fcrk","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b0985","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0169-409X(92)90008-E","article-title":"(D) Routes of delivery: Case studies:(8) The vaginal route of peptide and protein drug delivery","volume":"8","author":"Richardson","year":"1992","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b0990","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00038.2002","article-title":"Claudins create charge-selective channels in the paracellular pathway between epithelial cells","author":"Colegio","year":"2002","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.addr.2022.114293_b0995","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/jps.20107","article-title":"Permeability of tritiated water through human cervical and vaginal tissue","volume":"93","author":"Sassi","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1000","article-title":"Interfacing matrix release and membrane absorption-analysis of steroid absorption from a vaginal device in the rabbit doe","author":"Flynn","year":"1976","journal-title":"ACS Publications"},{"key":"10.1016\/j.addr.2022.114293_b1005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jps.2600660221","article-title":"Vaginal drug absorption in rhesus monkeys I: Development of methodology","volume":"66","author":"Owada","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jps.2600790304","article-title":"Characterization of the barrier properties of mucosal membranes","volume":"79","author":"Corbo","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2005.09.002","article-title":"Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa","volume":"305","author":"van Eyk","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1020","doi-asserted-by":"crossref","DOI":"10.1126\/science.105.2714.13.a","article-title":"Vaginal Absorption of Penicillin","volume":"105","author":"Rock","year":"1947","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114293_b1025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-9378(51)91171-4","article-title":"Absorption of penicillin through the human vagina: II. 500,000 units of penicillin at one administration","volume":"62","author":"Schudmak","year":"1951","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b1030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-5122(88)90066-7","article-title":"Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17\u03b2-oestradiol and progesterone in the pre- and post-menopause","volume":"10","author":"Carlstr\u00f6m","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.addr.2022.114293_b1035","series-title":"Vaginal microbicide formulations workshop","first-page":"1","author":"Barnhart","year":"1998"},{"key":"10.1016\/j.addr.2022.114293_b1040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmx028","article-title":"In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: a systematic review","volume":"24","author":"Ng","year":"2017","journal-title":"Hum. Reproduction Update"},{"key":"10.1016\/j.addr.2022.114293_b1045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000293657","article-title":"Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17\u03b2 and progesterone in postmenopausal women","volume":"27","author":"Pschera","year":"1989","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.addr.2022.114293_b1050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jps.2600720219","article-title":"Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats III: Effect of estrous cycle on vaginal absorption of hydrophilic model compounds","volume":"72","author":"Okada","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0015-0282(16)43454-0","article-title":"Human Cervical Mucus. IV. Viscoelasticity and Sperm Penetrability During the Ovulatory Menstrual Cycle**Supported by National Institutes of Health Contract NO1-HD-4-2838","volume":"30","author":"Wolf","year":"1978","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2022.114293_b1060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b1065","first-page":"65","article-title":"Physicochemical Characteristics of Molecules and Their Diffusion across Human Vaginal Mucosa, European","volume":"6","author":"Van Eyk","year":"2008","journal-title":"J. Inflamm."},{"key":"10.1016\/j.addr.2022.114293_b1070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1067\/mob.2002.126987","article-title":"Effect of vaginal pH on efficacy of the dinoprostone gel for cervical ripening\/labor induction","volume":"187","author":"Ramsey","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b1075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/jmf.13.4.250.253","article-title":"Effect of vaginal pH on efficacy of the controlled-release dinoprostone vaginal insert for cervical ripening\/labor induction","volume":"13","author":"Ramsey","year":"2003","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"10.1016\/j.addr.2022.114293_b1080","first-page":"1196","article-title":"Effect of vaginal pH on efficacy of dinoprostone gel for labour induction, International Journal of Reproduction, Contraception","volume":"5","author":"Kurian","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b1085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14767050500123863","article-title":"The effect of vaginal pH on labor induction with vaginal misoprostol","volume":"17","author":"Chandra","year":"2005","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"10.1016\/j.addr.2022.114293_b1090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"259","key":"10.1016\/j.addr.2022.114293_b1095","first-page":"e251","article-title":"A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial","volume":"221","author":"Haas","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114293_b1100","first-page":"152","article-title":"A review on vaginal drug delivery systems","volume":"1","author":"Krishna","year":"2012","journal-title":"Int J Biol Pharm Appl Sci"},{"key":"10.1016\/j.addr.2022.114293_b1105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/13625187.2012.713535","article-title":"The contraceptive vaginal ring, NuvaRing\u00ae, a decade after its introduction","volume":"17","author":"Roumen","year":"2012","journal-title":"Eur. J. Contraception Reproductive Health Care"},{"key":"10.1016\/j.addr.2022.114293_b1110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13625187.2017.1413179","article-title":"Pharmacokinetic bioequivalence, safety and acceptability of Ornibel\u00ae, a new polymer composition contraceptive vaginal ring (etonogestrel\/ethinylestradiol 11.00\/3.474 mg) compared with Nuvaring\u00ae (etonogestrel\/ethinylestradiol 11.7\/2.7 mg)","volume":"22","author":"Algorta","year":"2017","journal-title":"Eur. J. Contraception Reproductive Health Care"},{"key":"10.1016\/j.addr.2022.114293_b1115","article-title":"Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance","volume":"113855","author":"Vani\u0107","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b1120","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.fertnstert.2018.07.014","article-title":"Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization","volume":"110","author":"Ginsburg","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2022.114293_b1125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejogrb.2017.06.004","article-title":"Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy","volume":"216","author":"Fang","year":"2017","journal-title":"Eur. J. Obstetrics Gynecol. Reproductive Biol."},{"key":"10.1016\/j.addr.2022.114293_b1130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.fertnstert.2012.12.052","article-title":"Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study","volume":"99","author":"Stadtmauer","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2022.114293_b1135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14656566.2015.1035255","article-title":"Metronidazole for the treatment of vaginal infections","volume":"16","author":"Sobel","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.addr.2022.114293_b1140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/cpt.1212","article-title":"Current state of microbicide development","volume":"104","author":"Traore","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2022.114293_b1145","doi-asserted-by":"crossref","unstructured":"M.B. Guffey, B. Richardson, M. Husnik, B. Makanani, D. Chilongozi, E. Yu, G. Ramjee, N. Mgodi, K. Gomez, S.L. Hillier, S.A. Karim, H.I.V.P.T.N.S. Team, HPTN 035 phase II\/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women, Sexually Transmitted Infections 90 (2014) 363-369.","DOI":"10.1136\/sextrans-2014-051537"},{"key":"10.1016\/j.addr.2022.114293_b1150","doi-asserted-by":"crossref","unstructured":"S.S. Abdool Karim, B.A. Richardson, G. Ramjee, I.F. Hoffman, Z.M. Chirenje, T. Taha, M. Kapina, L. Maslankowski, A. Coletti, A. Profy, T.R. Moench, E. Piwowar-Manning, B. M\u00e2sse, S.L. Hillier, L. Soto-Torres, H.I.V.P.T.N.S. Team, Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women, AIDS (London, England), 25 (2011) 957-966.","DOI":"10.1097\/QAD.0b013e32834541d9"},{"key":"10.1016\/j.addr.2022.114293_b1155","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women","volume":"329","author":"Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.addr.2022.114293_b1160","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bmj.287.6401.1245","article-title":"Propranolol as a novel, effective spermicide: preliminary findings","volume":"287","author":"Zipper","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.addr.2022.114293_b1165","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4155\/tde-2017-0056","article-title":"Designing and developing suppository formulations for anti-HIV drug delivery","volume":"8","author":"Ham","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2022.114293_b1170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10517-020-04794-w","article-title":"Analysis of the Pharmacokinetics of Suppository Forms of Bacteriophages","volume":"168","author":"Bochkareva","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.addr.2022.114293_b1175","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1089\/aid.2015.0098","article-title":"A Phase 1 randomized, blinded comparison of the pharmacokinetics and colonic distribution of three candidate rectal microbicide formulations of tenofovir 1% Gel with simulated unprotected sex (CHARM-02)","volume":"31","author":"Hiruy","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.addr.2022.114293_b1180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/gut.35.3.353","article-title":"Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis","volume":"35","author":"Pullan","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.addr.2022.114293_b1185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2022.114293_b1190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota-brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.addr.2022.114293_b1195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.addr.2022.114293_b1200","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4155\/fmc-2020-0023","article-title":"The central role of gut microbiota in drug metabolism and personalized medicine","volume":"12","author":"Colotti","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.addr.2022.114293_b1205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/cpt1979266701","article-title":"Rectal bioavailability of lidocaine in man: partial avoidance of \u201cfirst-pass\u201d metabolism","volume":"26","author":"de Boer","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2022.114293_b1210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2004.03.030","article-title":"Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points","volume":"278","author":"Takatori","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1215","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1248\/bpb.28.1480","article-title":"Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid","volume":"28","author":"Takatori","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2022.114293_b1220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10837450701196565","article-title":"The preparation and evaluation of sustained release suppositories containing ketoprofen and Eudragit RL 100 by using factorial design","volume":"12","author":"Ozguney","year":"2007","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2022.114293_b1225","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2022.114293_b1230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2022.114293_b1235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13030336","article-title":"Mucoadhesive In Situ Rectal Gel Loaded with Rifampicin: Strategy to Improve Bioavailability and Alleviate Liver Toxicity","volume":"13","author":"Al-Joufi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b1240","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17425247.2011.586334","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"8","author":"das Neves","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.addr.2022.114293_b1245","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jphp.12136","article-title":"Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository","volume":"65","author":"Mohamed","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b1250","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s11095-013-1029-0","article-title":"Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect","volume":"30","author":"Seo","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b1255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.105.088146","article-title":"Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats","volume":"315","author":"Lamprecht","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2022.114293_b1260","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels\u2013review of temperature-sensitive systems","volume":"58","author":"Ruel-Gariepy","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2022.114293_b1265","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/10837450.2013.846373","article-title":"Properties of bioadhesive ketoprofen liquid suppositories: preparation, determination of gelation temperature, viscosity studies and evaluation of mechanical properties using texture analyzer by 4 x 4 factorial design","volume":"19","author":"Ozguney","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2022.114293_b1270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13318-013-0157-6","article-title":"In vitro-in vivo evaluation of in situ gelling and thermosensitive ketoprofen liquid suppositories","volume":"39","author":"Ozguney","year":"2014","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.addr.2022.114293_b1275","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2015.04.040","article-title":"Enema ion compositions for enhancing colorectal drug delivery","volume":"209","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1280","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119825","article-title":"Application of 3D printing technology for generating hollow-type suppository shells","volume":"589","author":"Tagami","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1290","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/jop.2019.0135","article-title":"Novel Ocular Drug Delivery Systems: An Update on Microemulsions","volume":"36","author":"Ustundag Okur","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2022.114293_b1295","doi-asserted-by":"crossref","unstructured":"A. Subrizi, E.M. del Amo, V. Korzhikov-Vlakh, T. Tennikova, M. Ruponen, A. Urtti, Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties, 2019, pp. 1446-1457.","DOI":"10.1016\/j.drudis.2019.02.001"},{"key":"10.1016\/j.addr.2022.114293_b1300","doi-asserted-by":"crossref","DOI":"10.1208\/pt040345","article-title":"Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir","volume":"4","author":"Tirucherai","year":"2003","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2022.114293_b1305","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2012.10.015","article-title":"Development of O\/W nanoemulsions for ophthalmic administration of timolol","volume":"440","author":"Gallarate","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1310","first-page":"535","article-title":"Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular","volume":"18","author":"Tirucherai","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2022.114293_b1315","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/02713680802270945","article-title":"Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride","volume":"33","author":"Kiran Vaka","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2022.114293_b1320","doi-asserted-by":"crossref","unstructured":"K. Zhang, L. Zhang, R.N. Weinreb, Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma, Nat. Rev. Drug Discovery 2012 11:7, 11 (2012) 541-559.","DOI":"10.1038\/nrd3745"},{"key":"10.1016\/j.addr.2022.114293_b1325","series-title":"Novel Drug Delivery Technologies: Innovative Strategies for Drug Re-positioning","first-page":"335","article-title":"Ophthalmic and Otic Drug Administration: Novel Approaches and Challenges","author":"Desai","year":"2019"},{"key":"10.1016\/j.addr.2022.114293_b1330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/imammb\/dqp019","article-title":"A model for wetting and evaporation of a post-blink precorneal tear film","volume":"27","author":"Winter","year":"2010","journal-title":"Math. Med. Biol.: A J. IMA"},{"key":"10.1016\/j.addr.2022.114293_b1335","first-page":"238","article-title":"Ocular Drug Delivery; Impact of in vitro Cell Culture Models","volume":"4","author":"Barar","year":"2009","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.addr.2022.114293_b1340","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2013.01.018","article-title":"Human corneal anatomy redefined: a novel pre-Descemet's layer","volume":"120","author":"Dua","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2022.114293_b1345","first-page":"11","article-title":"Permeation through cornea","volume":"39","author":"Malhotra","year":"2001","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.addr.2022.114293_b1350","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1006\/exer.2001.1056","article-title":"Shifting the paradigm of the blood-aqueous barrier","volume":"73","author":"Freddo","year":"2001","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2022.114293_b1355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00146764","article-title":"The blood-retinal barriers","volume":"41","author":"Cunha-Vaz","year":"1976","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.addr.2022.114293_b1360","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1365","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114293_b1370","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2022.114293_b1375","first-page":"93","article-title":"The intraocular dynamics of vancomycin hydrochloride ophthalmic ointment (TN-011) in rabbits, Journal of infection and chemotherapy : official journal of the Japan Society of","volume":"9","author":"Fukuda","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.addr.2022.114293_b1380","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1877912311202020082","article-title":"Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery","volume":"2","author":"Cholkar","year":"2012","journal-title":"Recent Patents Nanomed."},{"key":"10.1016\/j.addr.2022.114293_b1385","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","article-title":"Sustained subconjunctival drug delivery systems: current trends and future perspectives","volume":"40","author":"Rafiei","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.addr.2022.114293_b1390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2009.05.028","article-title":"Polyhydroxyethylaspartamide-based micelles for ocular drug delivery","volume":"378","author":"Civiale","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1395","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(03)01315-2","article-title":"Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats","volume":"557","author":"Ideta","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2022.114293_b1400","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jgm.1093","article-title":"Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters","volume":"9","author":"Tong","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.addr.2022.114293_b1405","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.gt.3301485","article-title":"In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles","volume":"8","author":"Liaw","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2022.114293_b1410","first-page":"678","article-title":"Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye, European journal of pharmaceutical sciences : official journal of the European Federation for","volume":"47","author":"Nagarwal","year":"2012","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1415","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/1061186X.2010.504268","article-title":"Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery","volume":"19","author":"Gupta","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2022.114293_b1420","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/mp900279c","article-title":"Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin\/prednisolone bitherapy","volume":"7","author":"Ibrahim","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1425","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/app.35229","article-title":"Pilocarpine-loaded poly(DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response","volume":"124","author":"Nair","year":"2012","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nano.2008.07.003","article-title":"Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application","volume":"5","author":"Agnihotri","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2022.114293_b1435","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/02713683.2018.1533983","article-title":"Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro","volume":"44","author":"Liu","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2022.114293_b1440","first-page":"205","article-title":"Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels","volume":"353","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1445","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3109\/03639041003680826","article-title":"PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate","volume":"36","author":"Gao","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1450","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/polym3020779","article-title":"Thermosensitive self-assembling block copolymers as drug delivery systems","volume":"3","author":"Bonacucina","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2022.114293_b1455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.drudis.2012.01.014","article-title":"Contact lenses in ocular therapeutics","volume":"17","author":"Gupta","year":"2012","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.addr.2022.114293_b1460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1465","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/17425241003770098","article-title":"Molecularly imprinted therapeutic contact lenses","volume":"7","author":"White","year":"2010","journal-title":"Expert opinion on drug delivery"},{"key":"10.1016\/j.addr.2022.114293_b1470","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920010794479673","article-title":"Disposition of nanoparticle-based delivery system via inner ear administration","volume":"11","author":"Chen","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.addr.2022.114293_b1475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2015.08.015","article-title":"Recent advances in local drug delivery to the inner ear","volume":"494","author":"El Kechai","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1480","doi-asserted-by":"crossref","first-page":"2008701","DOI":"10.1002\/adfm.202008701","article-title":"Drug Delivery across Barriers to the Middle and Inner Ear","volume":"31","author":"Zhang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2022.114293_b1485","article-title":"Drug Delivery for Treatment of Inner Ear Disease: Current State of Knowledge","volume":"31","author":"McCall","year":"2010","journal-title":"Ear Hear."},{"key":"10.1016\/j.addr.2022.114293_b1490","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MAO.0b013e3181a52773","article-title":"Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease, Otology & neurotology : official publication of the American Otological Society","volume":"30","author":"Alexander","year":"2009","journal-title":"Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol."},{"key":"10.1016\/j.addr.2022.114293_b1495","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/000348949009901113","article-title":"Titration streptomycin therapy for bilateral meniere's disease: Follow-up report","volume":"99","author":"Langman","year":"1990","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.addr.2022.114293_b1500","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2022.114293_b1505","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00261","article-title":"Inner ear therapeutics: An overview of middle ear delivery","volume":"13","author":"Patel","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.addr.2022.114293_b1510","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/17425247.2011.588207","article-title":"Intracochlear drug delivery systems","volume":"8","author":"Borenstein","year":"2011","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b1515","unstructured":"F. Kabi, G. Pharma, P. Bv, U. Co, P. Bv, C.O. Gmbh, P. Bv, C.O. Gmbh, P. Bv, H. Hydrochloride, H. Hydrochloride, H. Hydrochloride, H. Hydrochloride, Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, 2018, pp. 1-3."},{"key":"10.1016\/j.addr.2022.114293_b1520","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/joa.12344","article-title":"The development of the mammalian outer and middle ear","volume":"228","author":"Anthwal","year":"2016","journal-title":"J. Anat."},{"key":"10.1016\/j.addr.2022.114293_b1525","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.pcl.2013.04.014","article-title":"Otitis media and ear tubes","volume":"60","author":"Lambert","year":"2013","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.addr.2022.114293_b1530","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/03639045.2018.1464022","article-title":"Otic drug delivery systems: formulation principles and recent developments","volume":"44","author":"Liu","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1535","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2217\/imt.09.12","article-title":"Immunosuppressive therapy for autoimmune inner ear disease","volume":"1","author":"Buniel","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.addr.2022.114293_b1540","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.otc.2004.04.003","article-title":"The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption","volume":"37","author":"Banerjee","year":"2004","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.addr.2022.114293_b1545","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","article-title":"Neurotrophin signal transduction in the nervous system","volume":"10","author":"Kaplan","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.addr.2022.114293_b1550","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/bies.20502","article-title":"The molecular basis of neurosensory cell formation in ear development: a blueprint for hair cell and sensory neuron regeneration?","volume":"28","author":"Fritzsch","year":"2006","journal-title":"BioEssays : news and reviews in molecular, cellular and developmental biology"},{"key":"10.1016\/j.addr.2022.114293_b1555","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0378-5955(03)00138-2","article-title":"Quantitative interpretation of corticosteroid pharmacokinetics in inner fluids using computer simulations","volume":"182","author":"Plontke","year":"2003","journal-title":"Hear. Res."},{"key":"10.1016\/j.addr.2022.114293_b1560","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2010.02.003","article-title":"Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery","volume":"390","author":"Roy","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1565","author":"Merchant","year":"2010","journal-title":"Schuknecht's pathology of the ear"},{"key":"10.1016\/j.addr.2022.114293_b1570","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOO.0b013e32830e20db","article-title":"State-of-the-art mechanisms of intracochlear drug delivery","volume":"16","author":"Borkholder","year":"2008","journal-title":"Current Opinion in Otolaryngology and Head and Neck Surgery"},{"key":"10.1016\/j.addr.2022.114293_b1575","doi-asserted-by":"crossref","unstructured":"L. Sumner, J. Mestel, T. Reichenbach, Steady streaming as a method for drug delivery to the inner ear, Sci. Rep. 2021 11:1, 11 (2021) 1-12.","DOI":"10.1038\/s41598-020-79946-z"},{"key":"10.1016\/j.addr.2022.114293_b1580","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000358165","article-title":"Sustained Release of Triamcinolone Acetonide from an Intratympanically Applied Hydrogel Designed for the Delivery of High Glucocorticoid Doses","volume":"19","author":"Honeder","year":"2014","journal-title":"Audiol. Neurotol."},{"key":"10.1016\/j.addr.2022.114293_b1585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104564","article-title":"In Vitro and In Vivo Evaluation of a Hydrogel Reservoir as a Continuous Drug Delivery System for Inner Ear Treatment","volume":"9","author":"H\u00fctten","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114293_b1590","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0000000000000445","article-title":"A Novel Chitosan-Hydrogel-Based Nanoparticle Delivery System for Local Inner Ear Application, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of","volume":"36","author":"Lajud","year":"2015","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.addr.2022.114293_b1595","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.791573","article-title":"Nanocarriers for Inner Ear Disease Therapy","volume":"15","author":"Xu","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.addr.2022.114293_b1600","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2018.05.020","article-title":"Inner ear drug delivery: Recent advances, challenges, and perspective","volume":"126","author":"Hao","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1605","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1080\/21691401.2019.1573182","article-title":"Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities","volume":"47","author":"Mittal","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1610","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2022.114293_b1615","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtm.2021.03.005","article-title":"Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss","volume":"21","author":"Bankoti","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.addr.2022.114293_b1620","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4155\/tde.12.130","article-title":"Drug delivery to the ear","volume":"4","author":"Hoskison","year":"2013","journal-title":"Therapeutic delivery"},{"key":"10.1016\/j.addr.2022.114293_b1625","doi-asserted-by":"crossref","DOI":"10.1016\/S1359-6446(05)03574-9","article-title":"Local Inner Ear Drug Delivery and Pharmacokinetics","volume":"10","author":"Salt","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.addr.2022.114293_b1630","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","article-title":"Principles of Local Drug Delivery to the Inner Ear","volume":"14","author":"Salt","year":"2009","journal-title":"Audiology and Neurotology"},{"key":"10.1016\/j.addr.2022.114293_b1635","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00106-016-0285-9","article-title":"Intracochlear drug delivery in combination with cochlear implants: Current aspects","volume":"65","author":"Plontke","year":"2017","journal-title":"HNO"},{"key":"10.1016\/j.addr.2022.114293_b1640","first-page":"122","article-title":"Inner ear delivery: Challenges and opportunities, Laryngoscope Investigative","volume":"5","author":"Szeto","year":"2020","journal-title":"Otolaryngology"},{"key":"10.1016\/j.addr.2022.114293_b1645","first-page":"11","article-title":"Is oval window transport a royal gate for nanoparticle delivery to vestibule in the inner ear?, European journal of pharmaceutical sciences : official journal of the European Federation for","volume":"126","author":"Ding","year":"2019","journal-title":"Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2022.114293_b1650","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2217\/nnm-2019-0114","article-title":"Opportunities and challenging issues of nanomaterials in otological fields: An occupational health perspective","volume":"14","author":"Leso","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2022.114293_b1655","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13543776.2017.1252751","article-title":"Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review","volume":"27","author":"Nguyen","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.addr.2022.114293_b1660","first-page":"13652","article-title":"Preparation of chitosan nanoparticles and its utilization as novel powerful enhancer for both dyeing properties and antimicrobial activity of cotton fabrics, Biointerface Research in Applied","volume":"11","author":"Tawfik","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.addr.2022.114293_b1665","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2017.08.084","article-title":"Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery","volume":"532","author":"Cai","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1670","first-page":"28","article-title":"Inner ear drug delivery using liposomes, Cellular and molecular biology (Noisy-le-Grand","volume":"63","author":"Mohammadian","year":"2017","journal-title":"France)"},{"key":"10.1016\/j.addr.2022.114293_b1675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-32","article-title":"Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium","volume":"8","author":"Zou","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1680","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2016.02.013","article-title":"Hyaluronic acid liposomal gel sustains delivery of a corticoid to the inner ear","volume":"226","author":"El Kechai","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1685","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.3390\/molecules20058856","article-title":"Silver nanoparticles as potential antibacterial agents","volume":"20","author":"Franci","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2022.114293_b1690","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-015-0065-9","article-title":"Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection","volume":"13","author":"Zou","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1695","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s11274-014-1634-z","article-title":"Mycosynthesis and characterization of silver nanoparticles and their activity against some human pathogenic bacteria","volume":"30","author":"Muhsin","year":"2014","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1700","first-page":"606","article-title":"Study on synthesizing silver nanoparticles by using Muntingia calabura leaf extract: Insights from experimental and theoretical studies, Vietnam","volume":"59","author":"Tan Trung","year":"2021","journal-title":"J. Chem."},{"key":"10.1016\/j.addr.2022.114293_b1705","doi-asserted-by":"crossref","DOI":"10.1186\/s40104-019-0368-z","article-title":"Microbial synthesis of zinc oxide nanoparticles and their potential application as an antimicrobial agent and a feed supplement in animal industry: A review","volume":"10","author":"Mohd Yusof","year":"2019","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1710","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120428","article-title":"Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose","volume":"599","author":"Hasan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1715","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091464","article-title":"Solid lipid nanoparticles loaded with glucocorticoids protect auditory cells from cisplatin-induced ototoxicity","volume":"8","author":"Cervantes","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.addr.2022.114293_b1720","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/0366-6999.149202","article-title":"Solid lipid nanoparticles loaded with edaravone for inner ear protection after noise exposure","volume":"128","author":"Gao","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.addr.2022.114293_b1725","article-title":"Chitosan based hydrogels: characteristics and pharmaceutical applications","volume":"10","author":"Ahmadi","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1730","doi-asserted-by":"crossref","unstructured":"A. Gonz\u00e1lez-Paredes, L. Sitia, A. Ruyra, C.J. Morris, G.N. Wheeler, M. McArthur, P. Gasco, Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 134 (2019) 166-177.","DOI":"10.1016\/j.ejpb.2018.11.017"},{"key":"10.1016\/j.addr.2022.114293_b1735","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040938","article-title":"Dendrimers for Drug Delivery","volume":"23","author":"Chauhan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2022.114293_b1740","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2016.01.004","article-title":"Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss","volume":"108","author":"Li","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b1745","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4155\/tde.15.89","article-title":"Carbon nanotubes in drug delivery: Just a carrier?","volume":"7","author":"Roldo","year":"2016","journal-title":"Therapeutic Delivery"},{"key":"10.1016\/j.addr.2022.114293_b1750","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: New horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1755","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/21691401.2018.1478843","article-title":"Current advances in nanocarriers for biomedical research and their applications","volume":"46","author":"Rout","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1760","first-page":"347","article-title":"Role of nanoparticles in advanced biomedical research, Advances in Biological Science Research","author":"Kunkalekar","year":"2019","journal-title":"A Practical Approach"},{"key":"10.1016\/j.addr.2022.114293_b1765","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/acs.accounts.0c00280","article-title":"Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators","volume":"53","author":"Yang","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2022.114293_b1770","unstructured":"Nano Mat 2020: Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities-Adrien A Eshraghi-University of Miami-Miller School of Medicine, USA."},{"key":"10.1016\/j.addr.2022.114293_b1775","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000090685","article-title":"Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant","volume":"11","author":"Kopke","year":"2006","journal-title":"Audiol. Neuro-otology"},{"key":"10.1016\/j.addr.2022.114293_b1780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: a review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater. Res."},{"key":"10.1016\/j.addr.2022.114293_b1785","first-page":"209","article-title":"Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream","volume":"27","author":"Rovensky","year":"2001","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.addr.2022.114293_b1790","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1684\/ejd.2014.2293","article-title":"Efficacy and safety of clindamycin phosphate 1.2%\/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.addr.2022.114293_b1795","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for topical drug delivery: Potential for skin cancer treatment","volume":"153","author":"Krishnan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b1800","doi-asserted-by":"crossref","unstructured":"Y. Gilaberte, L. Prieto-Torres, I. Pastushenko, \u00c1. Juarranz, Anatomy and Function of the Skin, Elsevier Inc.2016.","DOI":"10.1016\/B978-0-12-802926-8.00001-X"},{"key":"10.1016\/j.addr.2022.114293_b1805","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-822550-9.00002-8","article-title":"Anatomy of the human skin","author":"Ita","year":"2020","journal-title":"Transdermal Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b1810","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.12968\/bjcn.2019.24.Sup3.S28","article-title":"A review of the effects of ageing on skin integrity and wound healing","volume":"24","author":"Bonifant","year":"2019","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.addr.2022.114293_b1815","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fsc.2017.03.001","article-title":"Anatomy of the Skin and the Pathogenesis of Nonmelanoma Skin Cancer","volume":"25","author":"Losquadro","year":"2017","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.addr.2022.114293_b1820","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13059","article-title":"Transdermal patches: history, development and pharmacology","volume":"172","author":"Pastore","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2022.114293_b1825","doi-asserted-by":"crossref","unstructured":"J.C.J. Wei, I.N. Haridass, M.L. Crichton, Y.H. Mohammed, S.C. Meliga, W.Y. Sanchez, J.E. Grice, H.A.E. Benson, M.S. Roberts, M.A.F. Kendall. Space- and time-resolved investigation on diffusion kinetics of human skin following macromolecule delivery by microneedle arrays. Sci. Rep., 8(2018):17759.","DOI":"10.1038\/s41598-018-36009-8"},{"key":"10.1016\/j.addr.2022.114293_b1830","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-015-9757-1","article-title":"Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy","volume":"37","author":"Hung","year":"2015","journal-title":"Age (Dordrecht, Netherlands)"},{"key":"10.1016\/j.addr.2022.114293_b1835","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1468-2494.2012.00744.x","article-title":"Emollients are more than sensory ingredients: the case of Isostearyl Isostearate","volume":"34","author":"Dederen","year":"2012","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1840","doi-asserted-by":"crossref","unstructured":"S.E. Kemp, Sensory evaluation: a practical handbook, Oxford : Wiley-Blackwell2009.","DOI":"10.1002\/9781118688076"},{"key":"10.1016\/j.addr.2022.114293_b1845","first-page":"163","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin. Pharmacol.: Adv. Applications"},{"key":"10.1016\/j.addr.2022.114293_b1850","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/smll.201201363","article-title":"Exposure to titanium dioxide nanoparticles induces autophagy in primary human keratinocytes","volume":"9","author":"Zhao","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.addr.2022.114293_b1855","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201816666190201143457","article-title":"Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies","volume":"16","author":"Benson","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.addr.2022.114293_b1860","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b1865","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0975-1483.55741","article-title":"Skin Penetration Enhancement Techniques","volume":"1","author":"Bharkatiya","year":"2009","journal-title":"J. Young Pharmacists"},{"key":"10.1016\/j.addr.2022.114293_b1870","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2014.05.022","article-title":"Transdermal drug delivery: 30+ years of war and still fighting!","volume":"190","author":"Wiedersberg","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1875","doi-asserted-by":"crossref","unstructured":"X. Jiang, P.B. Lillehoj, Microneedle-based skin patch for blood-free rapid diagnostic testing, Microsystems & Nanoengineering 2020 6:1, 6 (2020) 1-11.","DOI":"10.1038\/s41378-020-00206-1"},{"key":"10.1016\/j.addr.2022.114293_b1880","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41467-021-20948-4","article-title":"Transdermal electroosmotic flow generated by a porous microneedle array patch","volume":"12","author":"Kusama","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2022.114293_b1885","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102785","article-title":"Development, characterization and preclinical evaluation of nanosized liposomes of itraconazole for topical application: 32 full factorial design to estimate the relationship between formulation components","volume":"66","author":"Kumar","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b1890","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112351","article-title":"Formulation of liposomes loading lentisk oil to ameliorate topical delivery, attenuate oxidative stress damage and improve cell migration in scratch assay","volume":"144","author":"Allaw","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114293_b1895","doi-asserted-by":"crossref","unstructured":"J.K. Patra, G. Das, L.F. Fraceto, E.V.R. Campos, M.D.P. Rodriguez-Torres, L.S. Acosta-Torres, L.A. Diaz-Torres, R. Grillo, M.K. Swamy, S. Sharma, S. Habtemariam, H.S. Shin, Nano based drug delivery systems: Recent developments and future prospects 10 Technology 1007 Nanotechnology 03 Chemical Sciences 0306 Physical Chemistry (incl. Structural) 03 Chemical Sciences 0303 Macromolecular and Materials Chemistry 11 Medical and He, Journal of Nanobiotechnology, 16 (2018) 1-33.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"10.1016\/j.addr.2022.114293_b1900","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: An updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b1905","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.addr.2022.114293_b1910","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1164\/rccm.200504-613PP","article-title":"The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis","volume":"172","author":"Gelperina","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2022.114293_b1915","first-page":"29080","article-title":"Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects, RSC","volume":"11","author":"Mohd Nordin","year":"2021","journal-title":"Advances"},{"key":"10.1016\/j.addr.2022.114293_b1920","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1925","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-816506-5.00004-8","article-title":"Liposomes as topical drug delivery systems: State of the arts","author":"Rahman","year":"2019","journal-title":"Biomedical Applications of Nanoparticles"},{"key":"10.1016\/j.addr.2022.114293_b1930","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0169-409X(90)90021-J","article-title":"Liposomes as a topical drug delivery system","volume":"5","author":"Egbaria","year":"1990","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114293_b1935","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060866","article-title":"Formulations based on drug loaded aptamer-conjugated liposomes as a viable strategy for the topical treatment of basal cell carcinoma\u2014in vitro tests","volume":"13","author":"Cadinoiu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2022.114293_b1940","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/08982104.2020.1748646","article-title":"Formulation and evaluation of a topical liposomal gel containing a combination of zedoary turmeric oil and tretinoin for psoriasis activity","volume":"31","author":"Chen","year":"2021","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2022.114293_b1945","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejps.2016.10.025","article-title":"Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis","volume":"96","author":"Doppalapudi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b1950","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.addr.2022.114293_b1955","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/wnan.1211","article-title":"Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases","volume":"5","author":"Zhang","year":"2013","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2022.114293_b1960","article-title":"Nanoparticles for Dermal and Transdermal Drug Delivery, Application of Nanotechnology","author":"Uchechi","year":"2014","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b1965","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","article-title":"Nanoparticles: Emerging carriers for drug delivery","volume":"19","author":"Mudshinge","year":"2011","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.addr.2022.114293_b1970","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112101","article-title":"Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles","volume":"208","author":"Ferreira-Nunes","year":"2021","journal-title":"Colloids Surf., B: Biointerfaces"},{"key":"10.1016\/j.addr.2022.114293_b1975","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117295","article-title":"Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgaris","volume":"253","author":"Tolentino","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2022.114293_b1980","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b1985","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121217","article-title":"Isotretinoin-Delonix polymeric nanoparticles: Potentials for skin follicular targeting in acne treatment","volume":"610","author":"Ogunjimi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b1990","first-page":"123","article-title":"Nanoemulsion: an advanced mode of drug delivery system, 3","volume":"5","author":"Jaiswal","year":"2015","journal-title":"Biotech"},{"key":"10.1016\/j.addr.2022.114293_b1995","doi-asserted-by":"crossref","DOI":"10.3389\/fsufs.2019.00095","article-title":"Nanoemulsions and Their Potential Applications in Food Industry","volume":"3","author":"Aswathanarayan","year":"2019","journal-title":"Front. Sustain. Food Syst."},{"key":"10.1016\/j.addr.2022.114293_b2000","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: Formation, properties and applications","volume":"12","author":"Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2022.114293_b2005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/13102818.2019.1620124","article-title":"An overview of nanoemulsion: Concepts of development and cosmeceutical applications","volume":"33","author":"Marzuki","year":"2019","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.addr.2022.114293_b2010","doi-asserted-by":"crossref","DOI":"10.3390\/nano10050848","article-title":"Nanoemulgel for improved topical delivery of retinyl palmitate: Formulation design and stability evaluation","volume":"10","author":"Algahtani","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2022.114293_b2015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101847","article-title":"Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis","volume":"59","author":"Algahtani","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b2020","doi-asserted-by":"crossref","unstructured":"R.M. Martinez, W.V. Magalh\u00e3es, B.d.S. Sufi, G. Padovani, L.I.S. Nazato, M.V.R. Velasco, S.C.d.S. Lannes, A.R. Baby, Vitamin E-loaded bigels and emulsions: Physicochemical characterization and potential biological application, Colloids Surf. B: Biointerfaces, 201 (2021).","DOI":"10.1016\/j.colsurfb.2021.111651"},{"key":"10.1016\/j.addr.2022.114293_b2025","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.127677","article-title":"Pickering emulsions stabilized with chitosan\/collagen peptides nanoparticles as green topical delivery vehicles for cannabidiol (CBD)","volume":"631","author":"Sharkawy","year":"2021","journal-title":"Colloids Surf., A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.addr.2022.114293_b2030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijbiomac.2021.09.090","article-title":"Preparation, characterization, and application of polysaccharide-based emulsions incorporated with lavender essential oil for skin-friendly cellulosic support","volume":"191","author":"Danila","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2022.114293_b2035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-821222-6.00011-7","article-title":"Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances","author":"Abdel Samie","year":"2020","journal-title":"Drug Delivery Aspects"},{"key":"10.1016\/j.addr.2022.114293_b2040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425247.2013.746310","article-title":"Niosomes as a propitious carrier for topical drug delivery","volume":"10","author":"Hamishehkar","year":"2013","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b2045","article-title":"Niosomal drug delivery for transdermal targeting: recent advances, Research and Reports in Transdermal","volume":"4","author":"Muzzalupo","year":"2015","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2022.114293_b2050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-3659(94)90039-6","article-title":"Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery","volume":"30","author":"Schreier","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114293_b2055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/abm-2018-0002","article-title":"Niosomes: A review of their structure, properties, methods of preparation, and medical applications","volume":"11","author":"Yeo","year":"2017","journal-title":"Asian Biomed."},{"key":"10.1016\/j.addr.2022.114293_b2060","article-title":"Methods for preparation of niosomes: A focus on thin-film hydration method","author":"Thabet","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.addr.2022.114293_b2065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102441","article-title":"Topical delivery of cyclosporine loaded tailored niosomal nanocarriers for improved skin penetration and deposition in psoriasis: Optimization, ex vivo and animal studies","volume":"63","author":"Pandey","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b2070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120352","article-title":"Hair growth promoting effect of bioactive extract from deer antler velvet-loaded niosomes and microspicules serum","volume":"597","author":"Tansathien","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b2075","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/j.addr.2022.114293_b2080","first-page":"295","article-title":"Solid lipid nanoparticles for skin and drug delivery","author":"Amaldoss","year":"2019","journal-title":"Nanoarchitectonics in Biomedicine"},{"key":"10.1016\/j.addr.2022.114293_b2085","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.2174\/1381612826666200526145706","article-title":"Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status","volume":"26","author":"Liu","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2022.114293_b2090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119439","article-title":"Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: Optimization, characterization and cytotoxicity evaluation","volume":"586","author":"Kaur","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b2095","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1166\/jnn.2015.9184","article-title":"Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris","volume":"15","author":"Silva","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114293_b2100","first-page":"58","article-title":"Safranal-loaded solid lipid nanoparticles: Evaluation of sunscreen and moisturizing potential for topical applications","volume":"18","author":"Khameneh","year":"2015","journal-title":"Iranian J. Basic Med. Sci."},{"key":"10.1016\/j.addr.2022.114293_b2105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.colsurfb.2015.02.046","article-title":"Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles","volume":"128","author":"Kelidari","year":"2015","journal-title":"Colloids Surf., B: Biointerfaces"},{"key":"10.1016\/j.addr.2022.114293_b2110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jddst.2017.07.006","article-title":"Formulation and development of Silybin loaded solid lipid nanoparticle enriched gel for irritant contact dermatitis","volume":"41","author":"Shrotriya","year":"2017","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b2115","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S215153","article-title":"Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution","volume":"14","author":"Kang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2022.114293_b2120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102329","article-title":"Topical arginine solid lipid nanoparticles: Development and characterization by QbD approach","volume":"61","author":"Patel","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2022.114293_b2125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2018.11.072","article-title":"Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system","volume":"175","author":"Rostamkalaei","year":"2019","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.addr.2022.114293_b2130","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics8030089","article-title":"Skin care formulations and lipid carriers as skin moisturizing agents","volume":"8","author":"Pavlou","year":"2021","journal-title":"Cosmetics"},{"key":"10.1016\/j.addr.2022.114293_b2135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","article-title":"Cosmetic features and applications of lipid nanoparticles","volume":"30","author":"Souto","year":"2008","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.addr.2022.114293_b2140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-642-19792-5_14","article-title":"Nanocarriers and Cancer Therapy: Approaches to Topical and Transdermal Delivery","author":"Marchetti","year":"2011","journal-title":"Nanocosmetics Nanomed."},{"key":"10.1016\/j.addr.2022.114293_b2145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b2150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-2494.2007.00410.x","article-title":"Nanostructured lipid carriers as novel carrier for sunscreen formulations","volume":"29","author":"Xia","year":"2007","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.addr.2022.114293_b2155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/21691401.2014.909822","article-title":"Nanostructured lipid carriers and their current application in targeted drug delivery","volume":"44","author":"Jaiswal","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2022.114293_b2160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2022.114293_b2165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121179","article-title":"Determination of in vivo virtue of dermal targeted combinatorial lipid nanocolloidal based formulation of 5-fluorouracil and resveratrol against skin cancer","volume":"610","author":"Iqubal","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114293_b2170","first-page":"1034","article-title":"Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): In vitro and ex vivo studies, Nanomedicine: Nanotechnology","volume":"8","author":"Ara\u00fajo","year":"2012","journal-title":"Biology, and Medicine"},{"key":"10.1016\/j.addr.2022.114293_b2175","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S205295","article-title":"Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema","volume":"14","author":"Gao","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2022.114293_b2180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","article-title":"Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen","volume":"100","author":"Gonz\u00e1lez-Mira","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114293_b2185","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jphp.12543","article-title":"Clobetasol-loaded nanostructured lipid carriers for epidermal targeting","volume":"68","author":"Silva","year":"2016","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:32:40Z","timestamp":1759210360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X22001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":437,"alternative-id":["S0169409X22001831"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2022.114293","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and future perspectives in epithelial drug delivery","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2022.114293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114293"}}